Our findings suggest that pathological aggregates of TDP-43 in the human retina are most found in FTLD-TDP, ALS, and CTE, meaning these diseases may be the most feasible to accurately study the potential utility of TDP-43 as a retinal biomarker. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.